论文部分内容阅读
目的分析来曲唑促排卵治疗多囊卵巢综合征的临床疗效。方法随机选取28例耐克罗米芬的多囊卵巢综合征(PCOS)患者,按照数字随机表分为治疗组(14例)和对照组(14例),对照组采取尿促性素治疗,治疗组采取来曲唑片治疗,分析其治疗效果。结果治疗组促排卵效果明显优于对照组,差异有统计学意义(P<0.05)。治疗组排卵率为92.9%,对照组排卵率为64.3%;组间对比差异有统计学意义(P<0.05)。结论来曲唑促排卵治疗多囊卵巢综合征效果显著,提高患者的排卵率和妊娠率,临床价值高,值得临床推广。
Objective To analyze the clinical efficacy of letrozole ovulation in the treatment of polycystic ovary syndrome. Methods A total of 28 PCOS patients were randomly divided into treatment group (n = 14) and control group (n = 14). The control group was treated with urotensin, and the treatment group was taken Letrozole treatment, analysis of its therapeutic effect. Results Ovulation effect of the treatment group was significantly better than the control group, the difference was statistically significant (P <0.05). The ovulation rate was 92.9% in the treatment group and 64.3% in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion Letrozole ovulation treatment of polycystic ovary syndrome significant effect to improve the patient’s ovulation rate and pregnancy rate, high clinical value, it is worth clinical promotion.